Answers are grounded in this paper and cite their sources.
Background: Over 3.5 million US men are living with prostate cancer (PCa). Certain per- and polyfluoroalkyl substances (PFAS) are carcinogenic and impair cardiometabolic health. Due to comorbidities and treatment, men with PCa may be uniquely susceptible to PFAS. Objectives: To develop and validate a model for drinking water perfluorooctanoic acid (PFOA), perfluorooctane sulfonate (PFOS), and perfluorononanoic acid (PFNA), and study associations of each PFAS with all-cause, PCa, and cardiovascular disease (CVD) mortality in PCa survivors. Methods: We conducted a cohort study of 51,289 men with PCa diagnosed from 2006 to 2017 and followed through 2024 from the New Jersey (NJ) cancer registry. PFAS monitoring data (n=26,161 results) were obtained from NJ government evaluations and Community Water Systems (CWS) compliance reports and were used to estimate PFAS concentrations using a two-phase XGBoost model with 67 predictors of PFAS contamination across 566 CWS. PFAS predictions between 2006-2024 were linked to participant address histories. Adjusted hazard ratios (aHR) and 95% confidence intervals (CI) were estimated from Cox models with sociodemographic, clinical and time-varying neighborhood covariates. Results: There were 19,749 deaths, including 3,778 PCa deaths, and 4,972 CVD deaths over 466,843 person-years. Higher PFOA exposure was associated with all-cause mortality in certain quintiles (aHRQ2vsQ1: 1.07, 95% CI: 1.07-1.12; aHRQ3vsQ1: 1.06, 95% CI: 1.01-1.11) and with CVD mortality (aHRQ5vsQ1: 1.12, 95% CI: 1.01-1.24). Higher PFNA exposure was suggestively associated with all-cause mortality (aHR≥3.8ng/L vs <2ng/L: 1.22, 95% CI: 0.98-1.50) and PCa mortality (aHR≥3.8ng/L vs <2ng/L: 1.42, 95% CI: 0.96-2.10). Associations were strengthened when applying five-year lags. For example, higher PFOA (aHRQ5vsQ1: 1.15, 95% CI: 1.06-1.25), PFOS (aHRQ5vsQ1: 1.16, 95% CI: 1.07-1.25) and PFNA (aHR≥3.8ng/L vs <2ng/L: 1.57, 95% CI: 1.06-2.31) were associated with higher all-cause mortality. Discussion: Exposure to CWS-level PFAS was associated with higher mortality in PCa survivors. Replication is needed to confirm findings.
No takes yet. Share an insight, caveat, or question.
Iyer et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: